← Back to catalogue

cobas&#x00AE EBV

FDA UDI

Class II (US FDA UDI)

by Roche Molecular Systems, Inc.

Identity

Trade Name
cobas&#x00AE EBV FDA UDI
Generic Name
Epstein-Barr virus (EBV) nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Model / Reference
08688206190 FDA UDI

Identifiers

Catalog Number
08688206190 FDA UDI
Primary DI / UDI-DI
00875197006261 FDA UDI
FDA Product Code
QLX FDA UDI
GMDN Term
Epstein-Barr virus (EBV) nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3183 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Epstein-Barr virus (EBV) nucleic acid IVD, kit, nucleic acid technique (NAT)

cobas&#x00AE EBV by Roche Molecular Systems, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Epstein-Barr virus (EBV) nucleic acid IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Roche Molecular Systems, Inc.

Sources (1)

  • FDA UDI 8c44499e-fc65-4ef8-84b2-94d5fd4fe492 33 fields · synced Jun 9, 2026